Integra LifeSciences Holdings Corporation
IART · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $402 | $416 | $383 | $443 |
| % Growth | -3.3% | 8.6% | -13.6% | – |
| Cost of Goods Sold | $176 | $206 | $188 | $194 |
| Gross Profit | $226 | $209 | $194 | $249 |
| % Margin | 56.2% | 50.4% | 50.8% | 56.3% |
| R&D Expenses | $22 | $27 | $25 | $31 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $169 | $180 | $181 | $179 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$6 | $515 | $4 | $4 |
| Operating Expenses | $186 | $722 | $210 | $213 |
| Operating Income | $40 | -$513 | -$15 | $36 |
| % Margin | 10% | -123.4% | -4% | 8% |
| Other Income/Exp. Net | -$47 | -$18 | -$15 | -$13 |
| Pre-Tax Income | -$7 | -$531 | -$30 | $23 |
| Tax Expense | -$1 | -$47 | -$5 | $3 |
| Net Income | -$5 | -$484 | -$25 | $19 |
| % Margin | -1.3% | -116.5% | -6.6% | 4.4% |
| EPS | -0.07 | -6.33 | -0.33 | 0.25 |
| % Growth | 98.9% | -1,818.2% | -232% | – |
| EPS Diluted | -0.07 | -6.33 | -0.33 | 0.25 |
| Weighted Avg Shares Out | 77 | 76 | 76 | 77 |
| Weighted Avg Shares Out Dil | 77 | 76 | 76 | 77 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $5 | $2 | $5 |
| Interest Expense | $23 | $21 | $20 | $19 |
| Depreciation & Amortization | $38 | $38 | $37 | $37 |
| EBITDA | $54 | -$472 | $26 | $79 |
| % Margin | 13.4% | -113.6% | 6.8% | 17.9% |